Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Endometrial Neoplasms 3Endometrial Hyperplasia 2Overweight 1Obesity 1Neoplasms 1Gliosarcoma 1Glioblastoma 1

Interventions

Tirzepatide 5Resistance Training 3Exercise 2Counseling 2semaglutide 1mirabegron 1Weights and Measures 1Vitamin D 1Surveys and Questionnaires 1Stents 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Progestins 1Population Groups 1Observation 1Nutrition Assessment 1Negative-Pressure Wound Therapy 1Methods 1Metformin 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Hysteroscopy 1Hydroquinones 1Exercise Test 1Estrogen Replacement Therapy 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity × Progestins × 90 days × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡